• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 的抗体景观可以揭示新的疫苗和诊断靶点。

Antibody landscapes of SARS-CoV-2 can reveal novel vaccine and diagnostic targets.

机构信息

HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.

HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China; Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy; Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine, Assistance Publique-Hôpitaux de Paris, Hôpital Universitaire Paris Centre, Centre Hospitalier Universitaire Cochin, Service d'Immunologie Biologique, Paris, France; Institut Cochin, INSERM U1016, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

出版信息

Curr Opin Virol. 2021 Oct;50:139-146. doi: 10.1016/j.coviro.2021.08.006. Epub 2021 Aug 20.

DOI:10.1016/j.coviro.2021.08.006
PMID:34464844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8376662/
Abstract

SARS-CoV-2 virions are composed of structural proteins, but during virus infection, an additional 30 proteins could be expressed according to putative open reading frames (ORFs) of the viral genome. Some of these additional proteins modulate cellular processes through direct interactions, their truncations can affect disease pathogenesis and they can also serve as antigenic targets for more specific serology. In addition to structural proteins, the ORF1a/b polyprotein and accessory proteins can stimulate antibody responses during infection. Antibodies that target non-structural proteins can impact viral infection, through Fc mediated effector functions, through interactions during virus entry, fusion, replication and egress within infected cells. Characterization of the serological responses to additional proteins, provides a snapshot of the 'antibody landscape', which includes the antibody magnitude, antigenic specificity and informs the biological relevance of SARS-CoV-2 proteins.

摘要

SARS-CoV-2 病毒粒子由结构蛋白组成,但在病毒感染过程中,根据病毒基因组的推定开放阅读框(ORF),可能会表达另外 30 种蛋白。这些额外的蛋白中的一些通过直接相互作用来调节细胞过程,其截短会影响疾病发病机制,也可以作为更具特异性的血清学的抗原靶标。除了结构蛋白外,ORF1a/b 多蛋白和辅助蛋白可以在感染过程中刺激抗体反应。针对非结构蛋白的抗体可以通过 Fc 介导的效应功能,通过病毒进入、融合、复制和在感染细胞中释放过程中的相互作用,影响病毒感染。对额外蛋白的血清学反应的特征分析,提供了“抗体全景”的快照,其中包括抗体的幅度、抗原特异性,并为 SARS-CoV-2 蛋白的生物学相关性提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/044a/8376662/a4d4d30990c0/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/044a/8376662/a4d4d30990c0/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/044a/8376662/a4d4d30990c0/gr1_lrg.jpg

相似文献

1
Antibody landscapes of SARS-CoV-2 can reveal novel vaccine and diagnostic targets.SARS-CoV-2 的抗体景观可以揭示新的疫苗和诊断靶点。
Curr Opin Virol. 2021 Oct;50:139-146. doi: 10.1016/j.coviro.2021.08.006. Epub 2021 Aug 20.
2
Serological response in health care workers after a single dose of SARS-CoV-2 vaccine using six automated SARS-CoV-2 antibody assays.健康工作者接种一剂 SARS-CoV-2 疫苗后,使用六种自动化 SARS-CoV-2 抗体检测试剂的血清学反应。
Diagn Microbiol Infect Dis. 2021 Oct;101(2):115486. doi: 10.1016/j.diagmicrobio.2021.115486. Epub 2021 Jul 10.
3
The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity.用于检测SARS-CoV-2免疫的抗体检测的科学缺陷。
JAMA. 2021 Nov 9;326(18):1781-1782. doi: 10.1001/jama.2021.18919.
4
Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)B.1.617变体的感染及疫苗诱导的中和抗体反应
N Engl J Med. 2021 Aug 12;385(7):664-666. doi: 10.1056/NEJMc2107799. Epub 2021 Jul 7.
5
Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 priming.有或无前新冠病毒感染启动的情况下,SARS-CoV-2疫苗BNT162b2的抗体依赖性中和能力
J Intern Med. 2021 Dec;290(6):1272-1274. doi: 10.1111/joim.13366. Epub 2021 Aug 2.
6
SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans.SARS-CoV-2 mRNA 疫苗在免疫原性初免和预免疫人群中引发不同的反应。
Front Immunol. 2021 Sep 27;12:728021. doi: 10.3389/fimmu.2021.728021. eCollection 2021.
7
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.全面描述了针对 SARS-CoV-2 刺突蛋白的抗体反应,发现了除轻度感染诱导的表位之外的其他疫苗诱导的表位。
Elife. 2022 Jan 24;11:e73490. doi: 10.7554/eLife.73490.
8
SARS-CoV-2 Proteins: Are They Useful as Targets for COVID-19 Drugs and Vaccines?SARS-CoV-2 蛋白:它们是否可作为 COVID-19 药物和疫苗的靶点?
Curr Mol Med. 2022;22(1):50-66. doi: 10.2174/1566524021666210223143243.
9
Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection.SARS-CoV-2突破性感染后的抗体反应及变异株交叉中和作用
JAMA. 2022 Jan 11;327(2):179-181. doi: 10.1001/jama.2021.22898.
10
Comparison of neutralizing antibody responses against SARS-CoV-2 in healthy volunteers who received the BNT162b2 mRNA or the AZD1222 vaccine: Should the second AZD1222 vaccine dose be given earlier?接受BNT162b2 mRNA疫苗或AZD1222疫苗的健康志愿者中针对SARS-CoV-2的中和抗体反应比较:AZD1222疫苗的第二剂是否应提前接种?
Am J Hematol. 2021 Sep 1;96(9):E321-E324. doi: 10.1002/ajh.26248. Epub 2021 Jun 2.

引用本文的文献

1
Editorial overview: Viral pathogenesis.社论概述:病毒发病机制。
Curr Opin Virol. 2022 Aug;55:101253. doi: 10.1016/j.coviro.2022.101253. Epub 2022 Jul 8.
2
Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-β and IL-6 Secretion.核孔运输被 SARS-CoV-2 ORF6 蛋白阻碍,从而有效抑制 IFN-β 和 IL-6 的分泌。
Viruses. 2022 Jun 11;14(6):1273. doi: 10.3390/v14061273.
3
SARS-CoV-2 accessory proteins reveal distinct serological signatures in children.SARS-CoV-2 辅助蛋白在儿童中呈现出不同的血清学特征。

本文引用的文献

1
Antibody and B cell responses to SARS-CoV-2 infection and vaccination.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染和疫苗接种的抗体及B细胞反应。
Cell Host Microbe. 2021 Jul 14;29(7):1063-1075. doi: 10.1016/j.chom.2021.06.009. Epub 2021 Jun 17.
2
The landscape of antibody binding in SARS-CoV-2 infection.SARS-CoV-2 感染中抗体结合的全景。
PLoS Biol. 2021 Jun 18;19(6):e3001265. doi: 10.1371/journal.pbio.3001265. eCollection 2021 Jun.
3
An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies.
Nat Commun. 2022 May 26;13(1):2951. doi: 10.1038/s41467-022-30699-5.
4
T Cells Targeting SARS-CoV-2: By Infection, Vaccination, and Against Future Variants.靶向严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的T细胞:通过感染、疫苗接种以及针对未来变体
Front Med (Lausanne). 2021 Dec 24;8:793102. doi: 10.3389/fmed.2021.793102. eCollection 2021.
新冠病毒刺突蛋白上一个被抗体靶向的增强感染性位点。
Cell. 2021 Jun 24;184(13):3452-3466.e18. doi: 10.1016/j.cell.2021.05.032. Epub 2021 May 24.
4
Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domain.严重急性呼吸综合征冠状病毒2核衣壳蛋白的特征揭示了C末端结构域的多种功能后果。
iScience. 2021 Jun 25;24(6):102681. doi: 10.1016/j.isci.2021.102681. Epub 2021 Jun 1.
5
Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets.SARS-CoV-2 感染后 B 细胞免疫优势分析揭示了针对非中和性病毒靶点的抗体进化。
Immunity. 2021 Jun 8;54(6):1290-1303.e7. doi: 10.1016/j.immuni.2021.05.001. Epub 2021 May 6.
6
The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι.SARS-CoV-2 的 ORF8 蛋白通过下调 MHC-Ι 实现免疫逃逸。
Proc Natl Acad Sci U S A. 2021 Jun 8;118(23). doi: 10.1073/pnas.2024202118.
7
SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes.比较 44 种 Sarbecovirus 基因组分析 SARS-CoV-2 的基因组成和 COVID-19 的突变影响。
Nat Commun. 2021 May 11;12(1):2642. doi: 10.1038/s41467-021-22905-7.
8
Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.多水平蛋白质组学揭示 SARS-CoV-2 和 SARS-CoV 对宿主的干扰。
Nature. 2021 Jun;594(7862):246-252. doi: 10.1038/s41586-021-03493-4. Epub 2021 Apr 12.
9
Systems serology detects functionally distinct coronavirus antibody features in children and elderly.系统血清学在儿童和老年人中检测到功能不同的冠状病毒抗体特征。
Nat Commun. 2021 Apr 1;12(1):2037. doi: 10.1038/s41467-021-22236-7.
10
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.SARS-CoV-2 变体 B.1.351 和 P.1 逃避中和抗体。
Cell. 2021 Apr 29;184(9):2384-2393.e12. doi: 10.1016/j.cell.2021.03.036. Epub 2021 Mar 20.